Efficacy and safety of COVID-19 vaccines

Overview of attention for article published in Cochrane database of systematic reviews, December 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#32 of 12,927)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 7 news outlets
blogs: 4 blogs
twitter: 1291 tweeters

facebook: 5 Facebook pages
wikipedia: 1 Wikipedia page
video: 2 video uploaders

Citations

dimensions_citation: 62 Dimensions

Readers on

mendeley: 159 Mendeley

Summary News Blogs Twitter Facebook Wikipedia Video Dimensions citations

So far, Dimensions has found 62 publications that cite this research output.

62

The most recent citing publications are shown below. View all 62 publications that cite this research output on Dimensions.

Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation

Article in Expert Review of Clinical Immunology (September 2023)

mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis.

Article in Neurology Neuroimmunology & Neuroinflammation (September 2023)

Comparative effectiveness and duration of protection of ChAdOx1, CoronaVac, BNT162b2, mRNA-1273, and Ad26.COV2.S COVID-19 vaccines for symptomatic and hospitalized Mu, Delta, and Omicron: A test-negative case-control study

Article in Vaccine (September 2023)